04.05.2022AviadoBio to Present Pre-clinical Data on its Gene Therapy Candidate for Frontotemporal Dementia at ASGCT 2022

Press Release
03.05.2022Aura Biosciences Presents Preclinical Data Highlighting AU-011’s Anti-Tumor Activity in Choroidal Metastasis, an Additional Ocular Oncology Indication at the 2022 ARVO Annual Meeting

Press Release
02.05.2022Orphalan announces FDA approval of Cuvrior™ for the treatment of adult patients with stable Wilson’s disease who are de-coppered and tolerant to penicillamine

Press Release
27.04.2022ARGÁ MEDTECH SHOWS PROMISE FOR NEW CARDIAC ABLATION TECHNOLOGY AT 2022 HEART RHYTHM SOCIETY ANNUAL MEETING

Press Release
25.04.2022Novel CryptigenTM technology unlocks full potential of Tumour Specific Antigens

Press Release
14.04.2022Highlight Therapeutics announces follow-up results from Phase 2b study of BO-112 + anti-PD1 in confirmed anti-PD1 progressor melanoma patients at AACR

Press Release
15.03.2022Highlight Therapeutics to present at the American Association for Cancer Research (AACR) Annual Meeting 2022

In The News
08.03.2022MiroBio Continues Expansion of Executive Leadership Team with Key Appointments to Advance Development of Checkpoint Agonist Antibodies for Autoimmune Disease

Press Release
09.03.2022Aura Biosciences to Present Preclinical Data Highlighting AU 011’s Potential to Target a Broad Number of Tumor Types at the 2022 AACR Annual Meeting

Press Release
18.02.2022 Nalu Medical Inc. Announces $104 Million Equity Financing

Press Release